Consensus IMAX Corporation

Stocks

IMAX

CA45245E1097

Entertainment Production

Real-time Estimate Cboe BZX 00:07:47 17/10/2026 HKT			5-day change	1st Jan Change
51.60 ^USD	+0.11%		+1.81%	+39.94%

10-14	IMAX Has More to Come After Q3 'Victory' Lap, Wedbush Says	MT
10-14	Wedbush Raises Price Target on IMAX to $60 From $54, Keeps Outperform Rating	MT

Evolution of the Average Target: IMAX Corporation

Evolution of the Target Price: IMAX Corporation

Changes in Analyst Recommendations: IMAX Corporation

8b9869232ae288d43cf344a94.uCDC3Lv0R4oQ6-fLC3zKGmVaWkQYEjt4eKnvhMJVUZI.62yVpomkPtVfmNabTjCbUyoICSlVfFcCMfHatYMXF_bnbZqt9LkT_GGphA~4b94c900f7aee394a873c7d5e448d0ee

Analysts' recommendations: IMAX Corporation

10-14	IMAX Has More to Come After Q3 'Victory' Lap, Wedbush Says	MT
10-14	Wedbush Raises Price Target on IMAX to $60 From $54, Keeps Outperform Rating	MT
10-08	B. Riley Raises Price Target on IMAX to $64 From $61, Keeps Buy Rating	MT
09-24	Morgan Stanley Initiates IMAX at Overweight With $63 Price Target	MT
08-24	B. Riley Adjusts IMAX Price Target to $61 From $52, Maintains Buy Rating	MT
07-24	IMAX Q2 Results Reinforce Long-Term Growth Outlook, Wedbush Says	MT
07-24	Barrington Research Adjusts IMAX Price Target to $50 From $46, Maintains Outperform Rating	MT
07-24	B. Riley Adjusts Price Target on IMAX to $52 From $48, Maintains Buy Rating	MT
07-24	Wedbush Adjusts Price Target on IMAX to $54 From $46, Maintains Outperform Rating	MT
07-16	IMAX's H2 Outlook Remains Strong Despite Modest Q2 Growth, Wedbush Says	MT
07-16	Wells Fargo Downgrades IMAX to Equalweight From Overweight, Cuts Price Target to $41 From $47	MT
07-10	B. Riley Adjusts IMAX Price Target to $48 From $46, Maintains Buy Rating	MT
05-18	IMAX on Track to Reach $1.4 Billion in Box Office Proceeds Despite Headwinds, B. Riley Says	MT
05-04	Barrington Raises Price Target on IMAX to $46 From $42, Keeps Outperform Rating	MT
05-02	IMAX is Poised to Surpass 50% EBITDA Margins by 2028 on Rise in Filmed-for-IMAX Titles, Wedbush Says	MT
04-24	IMAX's Global Film Slate Likely to Support 'Robust' 2026, Wedbush Says	MT
04-18	B. Riley Upgrades 2026 Box Office Outlook Following First-Quarter Beat	MT
02-27	Macquarie Raises Price Target on IMAX to $45 From $44, Keeps Outperform Rating	MT
02-27	IMAX Poised to Benefit from Multiple Factors, Wedbush Says	MT
02-26	B. Riley Adjusts Price Target on IMAX to $46 From $44, Maintains Buy Rating	MT
12-15	JPMorgan Upgrades IMAX to Overweight From Neutral, Adjusts Price Target to $47 From $32	MT
12-09	IMAX EBITDA Margins Seen Surpassing 50% by 2028, Wedbush Says	MT
12-08	Wedbush Raises Price Target on IMAX to $46 From $39, Keeps Outperform Rating	MT
12-08	Barrington Raises Price Target on IMAX to $42 From $37, Keeps Outperform Rating	MT
12-08	B. Riley Raises Price Target on IMAX to $44 From $40, Keeps Buy Rating	MT

More recommendations

Other Entertainment Production

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	IMAX CORPORATION					+11.54%
	LIVE NATION ENTERTAINMENT, INC.					+17.19%
	UNIVERSAL MUSIC GROUP N.V.					+37.8%
	ROKU, INC.					+4.95%
	WARNER MUSIC GROUP CORP.					+23.82%
	BOLLORÉ SE					+13.98%
	MADISON SQUARE GARDEN SPORTS CORP.					+18.78%
	TOHO CO., LTD.					+13.8%
	PARAMOUNT SKYDANCE CORPORATION					+22.19%
	MANGO EXCELLENT MEDIA CO., LTD.					-18.02%
	Average					+14.60%
	Weighted average by Cap.					+18.53%